T-knife appoints Thomas Soloway as chief executive
T-knife GmbH, which is developing adoptive T cell therapies, has appointed Thomas Soloway as chief executive, and Camille Landis as chief business officer and chief financial officer, ahead of its transition from a discovery to a clinical-stage company.
Germany